Literature DB >> 2945916

Immunogenicity of plasma-derived hepatitis B vaccine: relationship to site of injection and obesity.

S M Lemon, D J Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2945916     DOI： 10.1007/bf02602339

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  16 in total

1.  Suboptimal response to hepatitis B vaccine given by injection into the buttock.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-03-01       Impact factor: 17.586

2.  Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine.

Authors:  D J Weber; W A Rutala; G P Samsa; J E Santimaw; S M Lemon
Journal:  JAMA       Date:  1985-12-13       Impact factor: 56.272

3.  Recommendations for protection against viral hepatitis.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-06-07       Impact factor: 17.586

4.  Low immune responses to hepatitis B vaccination among healthy subjects.

Authors:  P J Pead; A A Saeed; W G Hewitt; R N Brownfield
Journal:  Lancet       Date:  1985-05-18       Impact factor: 79.321

5.  Hepatitis B vaccine in a hospital.

Authors:  D M Schaaff; M Lender; P Snedeker; L A Graham
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

6.  Intramuscular or intralipomatous injections?

Authors:  W P Cockshott; G T Thompson; L J Howlett; E T Seeley
Journal:  N Engl J Med       Date:  1982-08-05       Impact factor: 91.245

7.  Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA.

Authors:  E M Scolnick; A A McLean; D J West; W J McAleer; W J Miller; E B Buynak
Journal:  JAMA       Date:  1984-06-01       Impact factor: 56.272

8.  The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

Authors:  D P Francis; S C Hadler; S E Thompson; J E Maynard; D G Ostrow; N Altman; E H Braff; P O'Malley; D Hawkins; F N Judson; K Penley; T Nylund; G Christie; F Meyers; J N Moore; A Gardner; I L Doto; J H Miller; G H Reynolds; B L Murphy; C A Schable; B T Clark; J W Curran; A G Redeker
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

9.  Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy.

Authors:  R R Redfield; B L Innis; R M Scott; H G Cannon; W H Bancroft
Journal:  JAMA       Date:  1985-12-13       Impact factor: 56.272

10.  Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses.

Authors:  K W Bernard; M A Roberts; J Sumner; W G Winkler; J Mallonee; G M Baer; R Chaney
Journal:  JAMA       Date:  1982-02-26       Impact factor: 56.272
View more
  3 in total

1.  Influence of skin-to-muscle and muscle-to-bone thickness on depth of needle penetration in adults at the deltoid intramuscular injection site.

Authors:  Nachiket Shankar; Deepali Saxena; Pooja P Lokkur; Nikhil M Kumar; Neena Chris William; Nirupama Vijaykumar
Journal:  Med J Armed Forces India       Date:  2014-10-16

Review 2.  The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

Authors:  Nelson F Eng; Nitin Bhardwaj; Rebecca Mulligan; Francisco Diaz-Mitoma
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

3.  The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route.

Authors:  Robert Edelman; Meagan E Deming; Franklin R Toapanta; Mark D Heuser; Lisa Chrisley; Robin S Barnes; Steven S Wasserman; William C Blackwelder; Barry S Handwerger; Marcela Pasetti; Khan M Siddiqui; Marcelo B Sztein
Journal:  Immun Ageing       Date:  2020-04-28       Impact factor: 6.400
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.